Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C91376
http://purl.obolibrary.org/obo/NCIT_C91376
|
|---|---|
| Preferred Name | Anti-VEGF Anticalin PRS-050-PEG40 |
| Definitions |
A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth. |
|---|---|
| prefLabel | Anti-VEGF Anticalin PRS-050-PEG40
|
| label | Anti-VEGF Anticalin PRS-050-PEG40
|
| NCI_META_CUI | CL421607
|
| PDQ_Closed_Trial_Search_ID | 675538
|
| code | C91376
|
| prefixIRI | NCIT:C91376
|
| in_subset | |
| Preferred_Name | Anti-VEGF Anticalin PRS-050-PEG40
|
| Maps_To | Anti-VEGF Anticalin PRS-050-PEG40
|
| NCI_Drug_Dictionary_ID | 675538
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 675538
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |